$AHCO News

AdaptHealth Corp. to Participate in Upcoming Investor Conferences

UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10

RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8

Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9

AdaptHealth: Fixed-Price Contracts Create Too Much Risk

AdaptHealth Corp. 2026 Q2 - Results - Earnings Call Presentation

AdaptHealth Corp. Q2 2026 Earnings Call Summary

AdaptHealth Q2 Earnings Call Highlights

AdaptHealth Shares Sink After Earnings Miss and Lower Full-Year Guidance

AdaptHealth (NASDAQ:AHCO) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 25.7%

AdaptHealth Corp. (AHCO) Q2 2026 Earnings Call Transcript

AdaptHealth Corp. Announces Second Quarter 2026 Results

UPDATE: AdaptHealth Q2 Adj. EPS $0.08 Misses $0.17 Estimate

AdaptHealth Lowers FY2026 Sales Guidance from $3.450B-$3.520B to $2.850B-$2.890B vs $3.488B Est

AdaptHealth Q2 EPS $(0.99) Misses $0.18 Estimate, Sales $740.300M Miss $848.627M Estimate

AdaptHealth (AHCO) Reports Earnings Tomorrow: What To Expect

AdaptHealth Corp.: Slimming Down Following The Sale Of The Diabetes Business

Jefferies Upgrades AdaptHealth to Buy, Raises Price Target to $13

AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call

AdaptHealth discloses patient data was stolen in cyberattack